Abstract
HIV can be acquired and transmitted during pregnancy. The adverse outcomes of HIV infection in pregnancy include spontaneous miscarriage, preterm delivery, intrauterine growth restriction, low birth weight and maternal mortality. Another major concern about HIV infection in pregnancy is the risk of transmission of the virus to the baby in utero, during delivery and in the postpartum period through breast milk. There is global call for the elimination of mother-to-child transmission of HIV. The application of current recommendations in the management of HIV-positive pregnant women has resulted in significant reduction in perinatal transmission risk of HIV from the base line value of 25–45% to less than 2% in many developed countries.
This chapter discusses the epidemiology of HIV, risk factors for HIV infection, mother-to-child transmission of HIV, prevention and treatment of HIV infection. The importance of HIV testing and counselling in pregnancy is highlighted. This chapter recommends that persons living with HIV infection should be provided reproductive health services including contraception until her health situation is optimised and safe for pregnancy. This chapter also recommends that all HIV-positive pregnant women should receive professional antenatal, intrapartum and postpartum care. Expert care for the HIV-exposed infant is also recommended for a successful outcome.
Note: Dolutegravir-based regimen should be avoided by women during preconception period and in first trimester of pregnancy due to risk of neural tube defect in their babies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 3TC:
-
Lamivudine 300 mg OD
- ART:
-
Antiretroviral therapy
- ATV/r:
-
Atazanavir/ritonavir 300 mg + 100 mg
- AZT:
-
Azidothymidine or zidovudine – ZDV 300 mg BD
- DRV/r:
-
Darunavir + ritonavir 800 mg +100 m OD
- DTG:
-
Dolutegravir 50 mg OD
- EFV:
-
Efavirenz 600 mg OD
- FTC:
-
Emtricitabine 200 mg OD
- LPV/r:
-
Lopinavir/ritonavir 400 mg + 100 mg
- NRTIs:
-
Nucleoside reverse transcriptase inhibitors
- NVP:
-
Nevirapine 200 mg OD for 14 days, then 200 mg BD
- RAL:
-
Raltegravir 400 mg OD
- TDF:
-
Tenofovir disoproxil fumarate 300 mg OD
References
UNAIDS. Global report: UNAIDS report on the global AIDS epidemic. Geneva: UNAIDS; 2012.
Dabis F, Leroy V, Castetbon K, et al. Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000. AIDS. 2000;14:1017–26.
Dabis F, Ekpini ER. HIV-1/AIDS and maternal and child health in Africa. Lancet. 2002;359:2097–104.
Pallela FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853–60.
Townsend C, Cortina-Borja M, Peckham C, Lyall H, de Ruiter A, Tookey P. Very low risk of mother-to-child transmission of HIV in women on HAART achieving viral suppression in the UK and Ireland. AIDS. 2008;22:973–81.
McKenna MT, Hu X. Recent trends in the incidence and morbidity that are associated with perinatal human immunodeficiency virus infection in the United States. Am J Obstet Gynecol. 2007;197:S10–6.
Mahy M, Stover J, Kirigu L, Hayashi C, Akwara P, Luo C, et al. What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect. 2010;86(Suppl 2):ii48–55.
Bartlett, JG, Gallant JE. Medical management of HIV infection. 2004th ed. Baltimore: Johns Hopkins Medicine Health Publishing Business Group, 2004.
US Department of Health and Human Services, Health Resources and Services. A guide to the clinical care of women with HIV/AIDS - 2013 edition. Rockville, Maryland. Department of Health and Human Services, Health Resources and Services. 2013. Available at: http://www.hab.hrsa.gov. Accessed 5 July 2016.
World Health Organization. WHO case definition of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, WHO. 2007. Available at: http://www.who.int/hiv/pub/guigelines/HIVstaging150307.pdf. Accessed 5 July 2016.
Agboghoroma OC. Gynaecological and reproductive health issues in HIV-positive women. West Afr J Med. 2010;29(3):135–42.
UNAIDS. Global AIDS update 2016. Global AIDS Response Progress Reporting (GARPR) 2016; UNAIDS 2016 estimates. Available at: http://wwwunaids.org. Accessed on 5 July 2016.
Federal Ministry of Health (FMOH). 2014. National HIV sero-prevalence sentinel survey among pregnant women attending antenatal clinics in Nigeria. Abuja. FMOH; 2015.
National Agency for the Control of AIDS (NACA). Nigeria HIV/AIDS Indicator and Impart Survey (NAIIS): national summary sheet. Abuja. NACA; 2019.
Agboghoroma OC, Giwa-Osagie OF. Infertility management in HIV-positive clients. Afr J Reprod Health. 2012;16(4):13–20.
French R, Brocklehurst P. The effect of pregnancy on survival in women infected with HIV: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol. 1998;105:827–35.
Ryder RW, Nsa W, Hassig SE, Behets F, Rayfield M, Ekungola B, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive woman in Zaire. N Engl J Med. 1989;320:1637–42.
Brocklehurst P, French R. The association between maternal HIV – infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol. 1998;105:836–48.
Khan KS, Wojdyia D, Say L, Gulmezoglu AM, Van Look PFA. WHO analysis of causes of maternal death: a systemic review. Lancet. 2006;367:1066–74.
The Working Group on Mother – to – Child Transmission of HIV. Rates of mother-to-child transmission of HIV I in Africa, America and Europe: result from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:506–10.
De Cock KM, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 2000;283:1175–82.
Rouzious C, Costagliola D, Burgard M, et al. Estimating timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model: the HIV infection in Newborns French Collaboration Study Group. Am J Epidemiol. 1995;142:1330–7.
Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breast-feeding. Lancet. 1992;340:585–8.
Garcia PM, Kalish IA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type I RNA and the risk of perinatal transmission. N Engl J Med. 1999;341:394–420.
British HIV Association. British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review). HIV Med. 2014;15(Suppl. 4):1–77.
Dickover R, Garratty E, Plaeger S, Bryson Y. Perinatal transmission of major, minor, and multiple HIV-I strains in Utero and intrapartum. 7th Conf. Retroviruses Opportunistic infect (Abst 181), Jan 30 Feb. 2, 2000.
Reinhardt PP, Reinhardt B, Lathey JL, Spector SA. Human cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage tropic human immunodeficiency virus type I isolates. J Clin Microbiol. 1995;233:292–7.
Kuhn L, Abrams EJ, Weedon J, et al. Disease progression and early viral dynamics in human immunodeficiency virus-infected children exposed to zidovudine during prenatal and perinatal periods. J Infect Dis. 2000;182:104–11.
Nimmagadda A, O’Brien WA, Goetz MB. The significance of vitamin A and carotenoid status in persons infected by the human immunodeficiency virus. Clin Infect Dis. 1998;26:711–8.
Turner BJ, Hauck WW, Fanning R, Markson LE. Cigarette smoking and maternal-child HIV transmission. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:427–37.
Lyman WD. Perinatal AIDS: drugs of abuse and transplacental infection. Adv Exp Med Biol. 1993;335:211–7.
Goldenberg RI, Vermund SH, Geopfert AR, Andrews WW. Choriodecidual inflammation: a potentially preventable cause of perinatal HIV-I transmission? Lancet. 1998;352:1927–30.
International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of HIV-I: a meta-analysis from fifteen prospective cohort studies (the International Perinatal HIV Group). N Engl J Med. 1999;340:977–87.
WHO/UNAIDS. HIV in pregnancy: a review WHO/CHS/RHR/99.15 and UNAIDS/99. 35E 1999.
Kostrikis LG, Neumann AU, Thomson B, et al. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type I to African – American infant. J Virol. 1999;73:10264–71.
UNICEF, UNAIDS, WHO. A review of HIV transmission through breast feeding. WHO/FRH/UNT/CHD 98.3 UNAIDS 98.5 UNICEF/PD/NUT (J) 98.3 Geneva 1998.
UNAIDS. Countdown to zero. Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. Geneva, UNAIDS; 2011.
Federal Ministry of Health. National guidelines for HIV prevention, treatment and care. Abuja: Federal Ministry of Health; 2016.
World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. 2nd ed. Geneva: World Health Organization; 2016.
World Health Organization. Updated recommendations on first line and second line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2018.
Cooper E, Charurar M, Burns DN, Blattner W, Hoff R. Trends in antiretroviral therapy and mother-infant transmissioin of HIV. The Women and Infants Transmission Study Group. J Acquir Immune Defic Syndr. 2000;24(1):45–7.
Royal College of Obstetricians and Gynaecologists. Management of HIV in pregnancy. Guideline No. 39, 2004. RCOG, London.
Cohen MS, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):496–505.
Galli L, Puliti D, Chiappini E, et al. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1? Clin Infect Dis. 2009;48(9):1310–7.
Agboghoroma OC. Management of HIV in pregnancy: a clinical review. Trop J Obstet Gynaecol. 2005;22(1):65–73.
Fawzi WW, Msamanga GI, Spiegelman D, Urassa EJN, McGrath N, Mwakagile D, et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes on T-cell counts in HIV-I infected women in Tanzania. Lancet. 1998;351:1477–82.
Ayisi JG, Van Ejik AM, Newman RD, ter Kuile FO, Shi YP, Yang C, et al. Maternal malaria and perinatal HIV transmission. Emerg Infect Dis. 2004;10(4):643–52.
Centres for Disease Control and Prevention. United States Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and Interventions to reduce perinatal HIV-1 transmission in the United States. MMWR 2002;51 (No. RR-18).
van Ham MA, van Dongen PJ, Mulder J. Maternal consequences of caesarean section. A retrospective study of intra-operative and post-operative maternal complications of caesarean section during a 10-year period. Eur J Obstet Gynecol Reprod Biol. 1997;74:1–6.
Agboghoroma OC. Contraception in the context of HIV/AIDS. A review. Afr J Reprod Health. 2011;15(3):15–23.
World Health Organization. Guidelines on HIV and infant feeding 2010. Geneva: World Health Organization; 2010.
Agboghoroma OC. Prevention of mother-to-child transmission of HIV/AIDS. In: Okonofua FE, editor. Confronting the challenge of reproductive health in Africa: a textbook for students and development practitioners. Benin: WHARC; 2014. p. 345–66.
Donnelly M, Davies JK. Contemporary management of human immunodeficiency virus in pregnancy. In: Swamy GK, Rayburn WF, editors. Obstet Gynaecol Clin North Am Infect Dis Pregnancy. 2014;41(4):547–67.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Agboghoroma, C.O. (2021). HIV in Pregnancy. In: Okonofua, F., Balogun, J.A., Odunsi, K., Chilaka, V.N. (eds) Contemporary Obstetrics and Gynecology for Developing Countries . Springer, Cham. https://doi.org/10.1007/978-3-030-75385-6_35
Download citation
DOI: https://doi.org/10.1007/978-3-030-75385-6_35
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-75384-9
Online ISBN: 978-3-030-75385-6
eBook Packages: MedicineMedicine (R0)